Gulf Biotech Company, a venture backed by Saudi investors, plans to set up a new insulin factory in Bahrain at an investment of $93 million, said a report.
The project is being backed by an alliance involving global multinationals
An early stage study suggests an experimental vaccine may be able to tame bits of the immune system that go haywire in people with type 1 diabetes, offering hope for a new way to delay or prevent the autoimmune disease, researchers said on Wedne
Bahrain is to set up an insulin production plant at a cost of BD35 million ($93 million) in line with its strategy to supply lifesaving products to people with diabetes across the Gulf region.
The Gulf Biotic facility will be constructed o
The number of babies with diabetes, who require insulin from birth, has tripled in Bahrain in the last 20 years, according to a health expert.
Latest figures show that 25 out of 100,000 babies were born with type one insulin dependent Diab
Pharmaceutical companies Bristol-Myers Squibb and AstraZeneca have announced results from an investigational phase 3b clinical study of use of Onglyza (saxagliptin) in diabetic patients.
The study was based on the addition of Onglyza (saxa
The molecular switch for the secretion of insulin — the hormone that regulates blood sugar — has been uncovered, providing for the first time an explanation of this process, said a report.
In a report published online recently in Cell Meta
Boehringer Ingelheim and Eli Lilly and Company today announced a global agreement to jointly develop and commercialise a portfolio of diabetes compounds currently in mid- and late-stage development.
Included are Boehringer Ingelheim’s two
Insulin, the sugar-regulating hormone, is required for normal bone development and it may provide a link between bone health and metabolic disease, such as diabetes, said a report.
The study, headed by Thomas Clemens, PhD, the Lewis Cass S
Sanofi-aventis has announced the results of new analysis that found a significantly lower risk of nocturnal hypoglycemia with Lantus (insulin glargine [rDNA] injection) as compared to NPH insulin.
A separate post-hoc sub-analysis found a g